Research on Pharmaceuticals Patents in Times of Big Data: A Contribution of the Web 2.0 for Medicinal Chemistry
- *Corresponding Author:
- Jorge Magalhaes
Oswaldo Cruz Foundation/FIOCRUZ–Farmanguinhos
Capes Fellow 12.298-3 (Brazil)
E-mail: [email protected]
Received Date: June 26, 2013; Accepted Date: August 21, 2013; Published Date: August 24, 2013
Citation: Magalhães J, Quoniam L, Ferreira V, PFerreira V, Boechat N (2013) Research on Pharmaceuticals Patents in Times of Big Data: A Contribution of the Web 2.0 for Medicinal Chemistry. Intel Prop Rights 1:105. doi: 10.4172/2375-4516.1000105
Copyright: © 2013 Magalhães J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This work aims to demonstrate the use of tools of Information Science applied to pharmaceutical patents. Given that existence of big data in the new century providing a massive and growing wave of information, it becomes necessary for new ways to rescue data and analyze them consistently. In the public health area is no different, especially with regard to intellectual property for new potential molecules to treat diseases of the global population. The triazoles were used as a study case due the great interest these compounds arouse in the pharmaceutical industry due their biological activities. In this regards, the approach are by consulting databases indexed (PubMed, Web of Science, Medline, Scopus, SciFinder Scholar), beyond to use search engines for data mining and software’s from collaborative intelligence to generate graphical analysis. The results demonstrate the potential of four series of triazoles derivatives and illustrate several correlations between patent and pharmaceutical industry extracted from the deep web.